Welcome to the new SADS site.
Click Here
to report any problems.
SADS Foundation USA
SADS Foundation Canada
SADS Foundation UK
SADS Foundation Netherlands
SADS Foundation China
SADS Foundation Hong Kong
Search for:
Log in
Supporting Families.
Saving Lives.
SADS International
SADS Blog
About Us
Contact Us
Library
Advocacy
Schools
Medical Professionals
Get Involved
Living with SADS
Research
Home
|
Research
|
Research Studies
|
Asymptomatic Brugada Syndrome
Empiric Quinidine for Asymptomatic Brugada Syndrome
Purpose:
The purpose of this study is to determine if Quinidine therapy (not guided by the results of electrophysiologic studies) will reduce the long-term risk of arrhythmic events in asymptomatic Brugada Syndrome.
Official Title:
A Prospective Trial Of Empiric Quinidine Therapy For Asymptomatic Brugada Syndrome.
Who Can Participate:
Patients with type I Brugada electrocardiogram (either spontaneous or following a drug challenge with sodium channel blocker) who never experienced arrhythmia-related symptoms. Patients will receive Quinidine therapy at the discretion of the attending physician.
The trial is registered at:
http://clinicaltrials.gov/ct2/show/NCT00789165?term=brugada&rank=2
More Information about the study:
http://www.brugadasyndrome.info/
For questions, contact Lynn Johnson, Director of Family Support, at 1-801-272-3023 or
Lynn@sads.org
.
TSA
Donate
About Us
Advocacy
International Partners
Schools
Dropbox
Medical Professionals
Get Involved
Library
Living with SADS
MatReqTest
Medical Professional Education
News
Press Room
Research
SADS Research Policy
Research Studies
SADS Young Investigator Award
SADS Int'l Conference
Shop for SADS Foundation Gear
Paypal Success
Paypal Failure
Thank you for your donation!
Volunteer to Fight SADS!
Overview of SADS Conditions
Online Community
SADS Online Support Community
Share Your Story
Stories: Living & Thriving with SADS
Stories: Forever in our Hearts
Enews Archives & Sign up
Find it Fast
Family Registration & Request Materials
Find a Physician
International SADS
Risk Assessment
Genetic Testing
Our Partners
Warning Signs
Family history of unexpected, unexplained sudden death under age 40.
Fainting or seizure during exercise, excitement or startle.
Consistent or unusual chest pain &/or shortness of breath during exercise.